Search Login Register

Malignant Atrophic Papulosis Summary

Description: Variously described as a vasculopathy, endovasculitis, or occlusive arteriopathy, this condition occurs in a benign cutaneous form and a lethal multiorgan systemic variant. It is characterized by a narrowing and occlusion of the lumen of small to medium-sized blood vessels, leading to ischemia and infarction in the involved organ systems. The etiology and pathophysiology are unknown.

Also Known As: Degos Syndrome; Degos's Malignant Atrophic Papulosis; Erythrokeratoderma en cocardes; Atrophic Papuloses, Malignant; Atrophic Papulosis, Malignant Show All >>

Networked: 96 relevant articles (2 outcomes, 2 trials/studies) for this Disease

Key Drugs and Agents for Malignant Atrophic Papulosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. eculizumab : 1 outcome in 2 results : FDA 2
  2. treprostinil : 1 outcome in 1 result : FDA 2
  3. Antibodies : 1 study in 3 results : IBA
  4. Retinoids : 1 study in 1 result : IBA
  5. Dichlorodiphenyldichloroethane (DDD) : 29 results : IBA
  6. Dental Porcelain (Porcelain) : 9 results : IBA
  7. Keratin-5 (Keratin 5) : 5 results : IBA
  8. Lupus Coagulation Inhibitor (Lupus Anticoagulant) : 3 results : IBA
  9. Immunoglobulins (Immunoglobulin) : 3 results : IBA
  10. Aspirin (Acetylsalicylic Acid) : 3 results : FDA 80 Generic
Show All >>

Diseases Related to Malignant Atrophic Papulosis

  1. Malignant Atrophic Papulosis
  2. Cicatrix (Scar)
  3. Hyperpigmentation
  4. Pyoderma Gangrenosum
  5. Vasculitis (Vasculitides)
Show All >>

Key Therapies for Malignant Atrophic Papulosis

Efficacy Chart >>
  1. Solid-State Lasers : 3 results
  2. Laparotomy : 2 results
  3. Transplants (Transplant) : 1 result
  4. Radiotherapy : 1 result
  5. PUVA Therapy : 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.